
Harness Therapeutics
Developer of a biotechnology platform designed to help the physiological upregulation of important neurodegenerative targets. The company utilizes mRNA-targeted oligonucleotides to modulate post-trans...
Valuation
$0
Share Price
N/A
Total Raised
$23M
Last Round
N/A